| DB ID | MyCo_5396 |
| Title | New approaches for the detection of invasive fungal diseases in patients following liver transplantation-results of an observational clinical pilot study |
| Year | 2019 |
| PMID | 30834971 |
| Fungal Diseases involved | Invasive fungal infection |
| Associated Medical Condition | Patients following liver transplantation |
| Genus | Candida |
| Species | glabrata |
| Organism | Candida glabrata |
| Ethical Statement | The observational clinical study was approved by the lo- cal ethics committee (Ethics Committee of the Medical Faculty of Heidelberg, Trial Code No. S-098/2013/ German Clinical Trials Register DRKS00005480) and conducted in the surgical intensive care unit of the Heidelberg University Hospital, Germany, between February 2014 and March 2016. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Germany |
| Cohort | In total, 93 patients were included in this study. |
| Cohort No. | 93 |
| Age Group | 42–58 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Bioinformatics analysis |
| Analysis Method | Next-generation sequencing (NGS)-based analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Next-generation sequencing (NGS)-based analysis |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
